Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer

Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis

(2019) Veeru Kasivisvanathan et al.   EUROPEAN UROLOGY

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer

(2019) Qin Feng et al.   Frontiers in Oncology

Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer

(2018) Jun Won Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Prostate Cancer Screening

(2018) William J. Catalona   MEDICAL CLINICS OF NORTH AMERICA

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ

(2018) Islam M. Miligy et al.   MODERN PATHOLOGY

c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer

(2018) Xuan Qu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma

(2018) Aysim Gunes et al.   Oncotarget

CAV3.1 knockdown suppresses cell proliferation, migration and invasion of prostate cancer cells by inhibiting AKT

(2018) Shanbiao Hu et al.   Cancer Management and Research

Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas

(2017) Zheng Cai et al.   International Journal of Clinical Oncology

TXNIP overexpression suppresses proliferation and induces apoptosis in SMMC7221 cells through ROS generation and MAPK pathway activation

(2017) Jian Li et al.   ONCOLOGY REPORTS

Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin

(2017) Althea N. Waldhart et al.   Cell Reports

Metabolic Alterations in Renal and Prostate Cancer

(2016) Chiara Ciccarese et al.   CURRENT DRUG METABOLISM

Fenofibrate suppressed proliferation and migration of human neuroblastoma cells via oxidative stress dependent of TXNIP upregulation

(2015) Cunjin Su et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling

(2015) Jianjun Han et al.   GYNECOLOGIC ONCOLOGY

Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP

(2015) Liangliang Shen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction

(2014) Mohan R. Kaadige et al.   MOLECULAR AND CELLULAR BIOLOGY

Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer

(2014) Jennifer A Morrison et al.   Molecular Cancer

The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein

(2014) Jungwon Hwang et al.   Nature Communications

AMPK-Dependent Degradation of TXNIP upon Energy Stress Leads to Enhanced Glucose Uptake via GLUT1

(2013) Ning Wu et al.   MOLECULAR CELL

Metabolic changes in cancer: beyond the Warburg effect

(2012) W. Wu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

The mutational landscape of lethal castration-resistant prostate cancer

(2012) Catherine S. Grasso et al.   NATURE

Thioredoxin Interacting Protein: Redox Dependent and Independent Regulatory Mechanisms

(2011) Oded N. Spindel et al.   ANTIOXIDANTS & REDOX SIGNALING

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Vitamin D3 Upregulated Protein 1 Suppresses TNF- -Induced NF- B Activation in Hepatocarcinogenesis

(2010) H.-J. Kwon et al.   JOURNAL OF IMMUNOLOGY